JCM
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JCM Accepts, published online ahead of print on 6 February 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JCM.02430-07v1
46/4/1298    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huzly, D
Right arrow Articles by Neumann-Haefelin, D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huzly, D
Right arrow Articles by Neumann-Haefelin, D

 Previous Article  |  Next Article 

J. Clin. Microbiol. doi:10.1128/JCM.02430-07
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

How accurate is measurement of anti-HBs in serum samples? Comparison of nine commercially available anti-HBs assays

D Huzly*, T Schenk, W Jilg, and D Neumann-Haefelin

Department of Virology, University Medical Center Freiburg, Freiburg, Germany, Institute of Medical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany

* To whom correspondence should be addressed. Email: daniela.huzly{at}uniklinik-freiburg.de.


   Abstract

Quantitative measurement of Anti-HBs is used to evaluate the response to Hepatitis B vaccination in health care workers and to optimize post exposure management. The different guidelines for Hepatitis B vaccination and booster policy imply, that measuring anti-HBs by different assays is accurate and consistent yielding comparable quantitative results. We measured 200 sera from patients and health care professionals in 9 different anti-HBs assays and compared the quantitative results and the performance characteristics of the different test systems. The assay specificity ranged between 96.8 and 100% defining sera from individuals without vaccination history and with negative anti-HBc status as true negatives. The sensitivity ranged between 83.9 and 100%. A high number of sera showed discrepancies between the values measured by the different systems. The mean coefficient of variation between the different measurements was 47.1% (range 15.0-201.0%), the factors of multiplication ranging between 2.8 and 105. Haemolysis or lipaemia did not seem to have an influence on the measurement, and there was no difference between anti-HBc-positive and –negative individuals. The classical EIAs tend to measure lower values than the automated systems, with higher values by the Abbott AXSYM. The serial dilution of the international standard preparation was measured accurately by most of the assays. In conclusion, the quantitative measurement of anti-HBs is not reliable, although an international standard is used for the calibration of the systems. Some systems showed specific problems that should be addressed by the manufacturer.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.